|
gptkbp:instanceOf
|
gptkb:cancer
gptkb:disease
|
|
gptkbp:affects
|
gptkb:Azalea
eye
choroid
ciliary body
|
|
gptkbp:associatedWith
|
gptkb:BAP1
gptkb:SF3B1
gptkb:GNA11
gptkb:EIF1AX
gptkb:GNAQ
|
|
gptkbp:canMetastasizeTo
|
gptkb:skin
lungs
liver
bones
|
|
gptkbp:clinicalTrialPhase
|
gptkb:NCT03830207
|
|
gptkbp:commonIn
|
gptkb:Caucasians
African descent
|
|
gptkbp:diagnosedBy
|
MRI
ultrasound
fluorescein angiography
ophthalmoscopy
|
|
gptkbp:firstDescribed
|
1809
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
uveal melanoma
|
|
gptkbp:ICD-10_code
|
gptkb:C69.3
|
|
gptkbp:incidence
|
about 5-7 cases per million per year
|
|
gptkbp:mostCommonPrimaryIntraocularCancerIn
|
adults
|
|
gptkbp:originatedIn
|
gptkb:uvea
|
|
gptkbp:prognosis
|
place
genetic mutations
tumor size
|
|
gptkbp:riskFactor
|
genetic predisposition
fair skin
light eye color
ultraviolet exposure
|
|
gptkbp:stageName
|
gptkb:COMS
gptkb:AJCC
|
|
gptkbp:subspecies
|
melanoma
|
|
gptkbp:symptom
|
blurred vision
visual disturbances
visual field loss
floaters
|
|
gptkbp:treatment
|
gptkb:proton_beam_therapy
radiation therapy
enucleation
local resection
plaque brachytherapy
|
|
gptkbp:bfsParent
|
gptkb:The_Cancer_Genome_Atlas_Research_Network
gptkb:Immunocore
gptkb:Gq_protein
|
|
gptkbp:bfsLayer
|
6
|